Skip to main content
Search

# ProteinMPNN

2 related articles

Subscribe to updates
  1. bioRxiv

    No trillion-sequence library needed: MobGen designs monobodies from scratch that bind SARS-CoV-2 RBD and neutralize B.1

    Monobodies, small binding proteins derived from a human fibronectin type III domain, previously required screening libraries of 3×1013 random sequences by phage display to find high-affinity binders against a viral antigen. MobGen chains RFdiffusion, AlphaFold2 backpropagation and ProteinMPNN into one computational pipeline; targeting the SARS-CoV-2 B.1 spike receptor-binding domain it generated 11,450 sequences, yielded 7 binders, and one of them neutralized B.1 pseudovirus at micromolar potency. Adding a C-terminal tail raised production about 7-fold on average and binding affinities reached 22.1–424.8 nM, but neutralization stayed around 2–25 µM and no monobody covered all tested variants.

  2. bioRxiv

    ProteinMPNN's latent space splits into readable axes for secondary structure, residue volume and heme coordination, and turning a branched-chain axis reshapes an antibody fragment's sequence

    Sparse autoencoders expand the dense 128-dimensional latent space at each ProteinMPNN encoder layer into an overcomplete sparse space, where individual dimensions correlate with protein features such as secondary structure, residue volume, residue shape, disulfide bridges and ligand coordination. On the Brolucizumab short-chain variable fragment, the mod=0, 0.5 and 1 candidates with branched-chain-amino-acid dimensions raised held lower RMSD at 433 K than the native sequence, the ProteinMPNN sequence and the GeoEvoBuilder sequence, while mod=2, the largest raise, unfolded substantially at that temperature; the unmodified mod=0 candidate improved too, showing the autoencoder itself shifts predictions.

You’re all caught up